Clinical Trial Update: 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 68Ga-RM2 PET/CT for detecting regional nodal and distant metastases in intermediate/high-risk prostate cancer; results posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-RM2

Snippet

Sponsor: Andrei Iagaru | Conditions: Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24